MLLCF Projected Dividend Yield
Namen Akt/Molecular Partners AG ( OTCBB : MLLCF )Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. Co. has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas. 21 YEAR PERFORMANCE RESULTS |
MLLCF Dividend History Detail MLLCF Dividend News MLLCF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |